BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 11801551)

  • 41. Matrix metalloproteinase-7 expression and biologic aggressiveness of cholangiocellular carcinoma.
    Miwa S; Miyagawa S; Soeda J; Kawasaki S
    Cancer; 2002 Jan; 94(2):428-34. PubMed ID: 11900228
    [TBL] [Abstract][Full Text] [Related]  

  • 42. (-)-Epigallocatechin-3-gallate promotes pro-matrix metalloproteinase-7 production via activation of the JNK1/2 pathway in HT-29 human colorectal cancer cells.
    Kim M; Murakami A; Kawabata K; Ohigashi H
    Carcinogenesis; 2005 Sep; 26(9):1553-62. PubMed ID: 15860507
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Vascular endothelial growth factor messenger RNA expression level is preserved in liver metastases compared with corresponding primary colorectal cancer.
    Kuramochi H; Hayashi K; Uchida K; Miyakura S; Shimizu D; Vallböhmer D; Park S; Danenberg KD; Takasaki K; Danenberg PV
    Clin Cancer Res; 2006 Jan; 12(1):29-33. PubMed ID: 16397020
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinicopathologic and prognostic significance of MMP-7 (matrilysin) expression in human rectal cancer.
    Luo HZ; Zhou ZG; Yang L; Yu YY; Tian C; Zhou B; Zheng XL; Xia QJ; Li Y; Wang R
    Jpn J Clin Oncol; 2005 Dec; 35(12):739-44. PubMed ID: 16314344
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Differences in the gene expression profile of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in primary colorectal tumors and their synchronous liver metastases.
    Gentner B; Wein A; Croner RS; Zeittraeger I; Wirtz RM; Roedel F; Dimmler A; Dorlaque L; Hohenberger W; Hahn EG; Brueckl WM
    Anticancer Res; 2009 Jan; 29(1):67-74. PubMed ID: 19331134
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Correlation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinase expression in ileal carcinoids, lymph nodes and liver metastasis with prognosis and survival.
    Voland P; Besig S; Rad R; Braun T; Baur DM; Perren A; Langer R; Höfler H; Prinz C
    Neuroendocrinology; 2009; 89(1):66-78. PubMed ID: 18708724
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Altered expression of metastasis-associated and regulatory molecules in effusions from breast cancer patients: a novel model for tumor progression.
    Davidson B; Konstantinovsky S; Nielsen S; Dong HP; Berner A; Vyberg M; Reich R
    Clin Cancer Res; 2004 Nov; 10(21):7335-46. PubMed ID: 15534110
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fecal cyclooxygenase 2 plus matrix metalloproteinase 7 mRNA assays as a marker for colorectal cancer screening.
    Takai T; Kanaoka S; Yoshida K; Hamaya Y; Ikuma M; Miura N; Sugimura H; Kajimura M; Hishida A
    Cancer Epidemiol Biomarkers Prev; 2009 Jun; 18(6):1888-93. PubMed ID: 19505922
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prognostic value of indoleamine 2,3-dioxygenase expression in colorectal cancer: effect on tumor-infiltrating T cells.
    Brandacher G; Perathoner A; Ladurner R; Schneeberger S; Obrist P; Winkler C; Werner ER; Werner-Felmayer G; Weiss HG; Göbel G; Margreiter R; Königsrainer A; Fuchs D; Amberger A
    Clin Cancer Res; 2006 Feb; 12(4):1144-51. PubMed ID: 16489067
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Increased expression of Wiskott-Aldrich syndrome protein family verprolin-homologous protein 2 correlated with poor prognosis of hepatocellular carcinoma.
    Yang LY; Tao YM; Ou DP; Wang W; Chang ZG; Wu F
    Clin Cancer Res; 2006 Oct; 12(19):5673-9. PubMed ID: 17020969
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibition mechanism of a newly cloned candidate tumor suppressor gene JST during hepatocarcinogenesis and its abnormal expression in human hepatocellular carcinoma from Qidong liver cancer risk area, China.
    Dong-Dong L; Xi-Ran Z
    Hepatogastroenterology; 2004; 51(56):515-25. PubMed ID: 15086194
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inhibitory effects of caffeic acid phenethyl ester on cancer cell metastasis mediated by the down-regulation of matrix metalloproteinase expression in human HT1080 fibrosarcoma cells.
    Hwang HJ; Park HJ; Chung HJ; Min HY; Park EJ; Hong JY; Lee SK
    J Nutr Biochem; 2006 May; 17(5):356-62. PubMed ID: 16214327
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Regulation of matrix metalloproteinase 13 expression by androgen in prostate cancer.
    Pang ST; Flores-Morales A; Skoog L; Chuan YC; Nordstedt G; Pousette A
    Oncol Rep; 2004 Jun; 11(6):1187-92. PubMed ID: 15138554
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Epigenetic inactivation of ID4 in colorectal carcinomas correlates with poor differentiation and unfavorable prognosis.
    Umetani N; Takeuchi H; Fujimoto A; Shinozaki M; Bilchik AJ; Hoon DS
    Clin Cancer Res; 2004 Nov; 10(22):7475-83. PubMed ID: 15569977
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Heparanase expression at the invasion front of human head and neck cancers and correlation with poor prognosis.
    Beckhove P; Helmke BM; Ziouta Y; Bucur M; Dörner W; Mogler C; Dyckhoff G; Herold-Mende C
    Clin Cancer Res; 2005 Apr; 11(8):2899-906. PubMed ID: 15837740
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Expression of matrix metalloproteinase 7, laminin and type IV collagen-associated liver metastasis in human colorectal cancer: immunohistochemical approach.
    Ogawa M; Ikeuchi K; Watanabe M; Etoh K; Kobayashi T; Takao Y; Anazawa S; Yamazaki Y
    Hepatogastroenterology; 2005; 52(63):875-80. PubMed ID: 15966224
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Epidermal growth factor receptor (EGFR) mRNA levels and protein expression levels in primary colorectal cancer and corresponding liver metastases.
    Kuramochi H; Hayashi K; Nakajima G; Kamikozuru H; Yamamoto M; Danenberg KD; Danenberg PV
    Cancer Chemother Pharmacol; 2010 Apr; 65(5):825-31. PubMed ID: 19701635
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Matrix metalloproteinase-9,-3 and tissue inhibitor of matrix metalloproteinase-1 in colorectal cancer: relationship to clinicopathological variables.
    Işlekel H; Oktay G; Terzi C; Canda AE; Füzün M; Küpelioğlu A
    Cell Biochem Funct; 2007; 25(4):433-41. PubMed ID: 16615041
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hepatic expression of ANG2 RNA in metastatic colorectal cancer.
    Ogawa M; Yamamoto H; Nagano H; Miyake Y; Sugita Y; Hata T; Kim BN; Ngan CY; Damdinsuren B; Ikenaga M; Ikeda M; Ohue M; Nakamori S; Sekimoto M; Sakon M; Matsuura N; Monden M
    Hepatology; 2004 Feb; 39(2):528-39. PubMed ID: 14768007
    [TBL] [Abstract][Full Text] [Related]  

  • 60. E1A-F is overexpressed early in human colorectal neoplasia and associated with cyclooxygenase-2 and matrix metalloproteinase-7.
    Boedefeld WM; Soong R; Weiss H; Diasio RB; Urist MM; Bland KI; Heslin MJ
    Mol Carcinog; 2005 May; 43(1):13-7. PubMed ID: 15800927
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.